Avoiding future controversies in the Alzheimer’s disease space through understanding the aducanumab data and FDA review

Overview of attention for article published in Alzheimer's Research & Therapy, May 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 15 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 1 news story.

Avoiding future controversies in the Alzheimer's disease space through understanding the aducanumab data and FDA review.

Alzforum, 26 May 2023

Dickson SP, Hennessey S, Nicodemus Johnson J, Knowlton N, Hendrix SB. Alzheimers Res Ther.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.